June 13, 2013
/PRNewswire/ -- American Capital, Ltd. (NASDAQ: ACAS) ("American Capital" or the "Company") announced that at a meeting today, its Board of Directors voted to increase the size of the Board to nine and elected
Susan K. Nestegard
to the newly created position.
"We are very excited to have Susan join our Board of Directors," said
, Chairman and Chief Executive Officer. "She brings a wealth of corporate operational experience and insight, which will be invaluable to American Capital as we continue to invest in middle market companies and offer them large corporate expertise to enhance their performance. I expect she will contribute in many important ways in the years ahead and be a great addition to our Board."
Ms. Nestegard is former Executive Vice President and President, Global Healthcare Sector, of Ecolab Inc., a provider of water, hygiene and energy technologies and services. She led the healthcare sector from 2008 to 2012, and was Senior Vice President, Research, Development and Engineering, and Chief Technical Officer for Ecolab from 2003 to 2008. Ms. Nestegard also has over 20 years experience with 3M Company in research and development, technology leadership, and business management. Since 2009, she has been a Director of Hormel Foods Corporation (NYSE: HRL).
ABOUT AMERICAN CAPITAL
American Capital, Ltd. (NASDAQ: ACAS) is a publicly traded private equity firm and global asset manager. American Capital, both directly and through its asset management business, originates, underwrites and manages investments in middle market private equity, leveraged finance, real estate and structured products. American Capital manages
of assets, including assets on its balance sheet and fee earning assets under management by affiliated managers, with
of total assets under management (including levered assets). From its eight offices in the U.S. and
, American Capital and its affiliate, European Capital, will consider investment opportunities from
$10 million to $750 million
. For further information, please refer to
Media – (301) 968-9400Investor Relations - (301) 951-5917